Conference Details - Overview
Continuing Education Information
The University of Texas M. D. Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Texas M. D. Anderson Cancer Center designates this educational activity for a maximum of 12.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CME Certificates and Attendance Verification Certificates
Certificates awarding AMA PRA Category 1 Credit™ or certificates documenting attendance will be distributed on-site to participants when an individual departs the conference. To obtain a CME certificate, physicians must submit a completed evaluation questionnaire and a CME Verification Form.
Upon request, a record of attendance (certificate) will be provided on-site at the Registration Desk to other health care professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.
Evaluation
A course evaluation form will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, and possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.
Oncology Practice Reviews
*Part of a PER conference series [ View Series Overview ]
George R. Brown Convention Center
Houston, TX
March 12-13, 2010
Conference Overview
Overview and Purpose
This activity is sponsored by The University of Texas M. D. Anderson Cancer Center, along with medical education partner, Physicians’ Education Resource.
Oncology Practice Reviews is a 2-day symposium designed to educate community physicians on the state-of-the-art clinical management of a wide variety of solid and hematologic malignancies. Lectures will highlight cutting-edge information and emerging treatment strategies for specific tumor types, including breast cancer, genitourinary malignancies, lymphoma, gastrointestinal malignancies, lung cancer, multiple myeloma, myelodysplastic syndromes, leukemia, and chronic lymphocytic leukemia, in addition to other special topics unique to each meeting location. To enhance learning, participants will be engaged in solving “real-world” problems through practical, interactive, case-based presentations.
Product Theaters
Industry-led lectures and exhibits will be conducted in conjunction with this event to provide promotional product-specific information on available agents and products in development.
These optional activities are not certified for CME credit and are not planned or sanctioned by PER.
Educational Methods
Lectures, Questions-and-Answers, Case-Based Panel Discussions, Audience Response System
Target Audience
This educational program is directed toward medical oncologists and hematologists practicing in the community or academic setting who are interested in recent advances in the treatment of solid tumors and hematologic malignancies. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of cancer are also invited to attend.
Learning Objectives
At the conclusion of this symposium, you should be able to:
- Assess the efficacy and safety of targeted agents in the management of patients with solid tumors and hematologic malignancies
- Summarize new data that might influence current treatment and monitoring strategies for patients with newly diagnosed leukemia, lymphoma, and myeloma
- Interpret the significance of clinical and molecular characteristics in choosing therapies for patients with solid tumors
- Identify results of recent clinical trials that are currently applicable to the management of patients with solid tumors and hematologic malignancies
The University of Texas M. D. Anderson Cancer Center has implemented a process whereby everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest that could potentially affect the information presented. M. D. Anderson also requires that all faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products. Specific disclosure will be made to the participants prior to the educational activity.
Agendas are subject to change because we are always striving to improve the quality of your educational experience. M. D. Anderson may substitute faculty with comparable expertise on rare occasions necessitated by illness, scheduling conflicts, and so forth.
Photographing, audiotaping, and videotaping are prohibited.
Please let us know what specific topics, issues, or questions you wish to see addressed or emphasized in this activity. Fax or e-mail CME/Conference Management. All responses will be forwarded to the Program Chair(s) for consideration